Evidence map›Paper›PMID 11158590›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

p53 accumulates but is functionally impaired when DNA synthesis is blocked.

V Gottifredi, S Shieh, Y Taya, C Prives

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 149 citations in OpenAlex.

  1. Article
  2. Review
  3. Myeloproliferative Neoplasms: Challenging Dogma.Journal of clinical medicine · 2024
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Functional relationship between p53 and RUNX proteins.Journal of molecular cell biology · 2019
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

V GottifrediDepartment of Biological Sciences, Columbia University, New York, NY 10027, USA.
S Shieh
Y Taya
C Prives
Columbia University · US

Funding

Regulation of the p53 tumor suppressor proteinR01CA058316 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI PRIVES, CAROL · 1993 to 2017
$5.3M
REGULATION OF THE P53 TUMOR SUPPRESSOR PROTEINR37CA058316 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI PRIVES, CAROL · 1998 to 2007
$3.8M
NCI NIH HHS CA 58316NCI NIH HHS R01 CA058316NCI NIH HHS R37 CA058316
6 · The paper itself

Abstract

p53 is required for the induction of a G(1) and/or G(2) irreversible arrest after gamma irradiation (IR), whereas blocked DNA replication causes a p53-independent S-phase arrest. We have examined the response to p53 when DNA synthesis is blocked by hydroxyurea (HU) or aphidicolin or when DNA is damaged by gamma IR. Similarly to gamma IR, blocked DNA synthesis induces high levels of phosphorylated nuclear p53. Surprisingly, several (but not all) p53 transcriptional targets that are rapidly induced by gamma IR are weakly or not induced when DNA replication is blocked. Moreover, the p53 response to gamma IR is inhibited by pretreatment of cells with HU or aphidicolin, suggesting that blocked DNA replication prevents p53 from being fully active as a transcription factor. HU-induced stabilization of p53 neither requires functional ATM (ataxia telangiectasia mutated), nor interferes with the gamma IR-dependent activation of the ATM kinase. Thus, stalled replication forks activate kinases that modify and stabilize p53, yet act downstream of ATM to impair p53 transcriptional activity. The ramifications of this novel regulation of p53 are discussed.

Indexed as

Transcription, GeneticAtaxia Telangiectasia Mutated ProteinsCell CycleCell Cycle ProteinsColorectal NeoplasmsDNA-Binding ProteinsDNA ReplicationG1 PhaseG2 PhaseGamma RaysHumansProtein Serine-Threonine KinasesTranscription FactorsTumor Cells, CulturedTumor Suppressor Protein p53Tumor Suppressor ProteinsAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDNA-Binding ProteinsProtein Serine-Threonine KinasesTranscription FactorsTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID11158590
PMCPMC14704
OpenAlexW2044134416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.